APOA1 and amyotrophic lateral sclerosis: While some studies are contradictory concerning the effects of lipid metabolism in ALS, patients experience an imbalance in LDL/HDL and ApoB/ApoA1 levels that has been linked to pathologic hyperlipidemic, atherosclerotic, and pro-inflammatory EC damage in ALS [85,86,87].